Comparative Pharmacology
Head-to-head clinical analysis: BUTALBITAL ACETAMINOPHEN AND CAFFEINE versus ESGIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BUTALBITAL ACETAMINOPHEN AND CAFFEINE versus ESGIC.
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE vs ESGIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Butalbital is a barbiturate that acts as a nonselective central nervous system depressant, enhancing GABAergic transmission by binding to the GABA-A receptor and increasing chloride influx, leading to sedation and anxiolysis. Acetaminophen inhibits cyclooxygenase (COX) enzymes centrally, reducing prostaglandin synthesis and providing analgesic and antipyretic effects. Caffeine is a methylxanthine that antagonizes adenosine receptors, promoting vasoconstriction and enhancing analgesic efficacy.
Esgic contains butalbital (a barbiturate that enhances GABA-A receptor activity, producing sedation), acetaminophen (inhibits cyclooxygenase, particularly COX-2, in the CNS, reducing pain and fever), and caffeine (antagonizes adenosine receptors, providing vasoconstriction and adjuvant analgesic effect).
1-2 capsules (50mg butalbital, 300mg acetaminophen, 40mg caffeine) orally every 4 hours as needed, not to exceed 6 doses per day.
1-2 capsules (50 mg butalbital, 325 mg acetaminophen, 40 mg caffeine) orally every 4 hours as needed, not to exceed 6 capsules per day.
None Documented
None Documented
Butalbital: 35-50 hours (long-acting barbiturate, risk of accumulation with repeated dosing). Acetaminophen: 2-4 hours (normal hepatic function). Caffeine: 3-7 hours (metabolized by CYP1A2).
Butalbital: ~35 hours; acetaminophen: ~2-3 hours; caffeine: ~3-6 hours. Clinical context: butalbital's long half-life leads to accumulation with repeated dosing, requiring cautious use.
Butalbital: ~90% renal as unchanged drug and metabolites; Acetaminophen: ~85% renal as sulfate and glucuronide conjugates; Caffeine: ~1% renal unchanged, primarily hepatic metabolism. Biliary/fecal minimal (<5%).
Renal: butalbital 60-70% unchanged, acetaminophen ~4% unchanged, caffeine ~1% unchanged. Biliary/fecal: minimal.
Category C
Category C
Barbiturate Combination
Barbiturate Combination